Immugen BioPharma, Inc.
Biotechnology ResearchFlorida, United States2-10 Employees
Our mission is to harness the endocannabinoid system for women's health based on results from an NIH funded grant.
Innovative Focus Immugen BioPharma specializes in leveraging the endocannabinoid system for women's health, presenting a unique niche that appeals to organizations involved in personalized medicine, women’s health, and biotechnology innovation.
Growth Potential With an annual revenue estimated between 1 million and 10 million and a small team of up to 10 employees, the company is positioned for significant growth and might be receptive to solutions that support scaling research and development efforts.
Technology Stack Utilizing cloud-based tools such as Google Cloud and Sentry, along with website builders like Wix and GoDaddy, suggests openness to innovative digital solutions and technology integrations that can optimize their online presence and research data management.
Funding Opportunities Given their NIH-funded research background, Immugen may be interested in partnerships, grants, or funding programs that advance biotech research, especially those aligned with cannabinoid science and women's health initiatives.
Market Positioning Operating within a highly competitive biotech landscape with major players generating multi-billion dollar revenues, Immugen can benefit from outreach that emphasizes its innovative approach, niche focus, and potential for rapid development and partnerships.
Immugen BioPharma, Inc. uses 8 technology products and services including GoDaddy Website Builder, Wix eCommerce, Sirvoy, and more. Explore Immugen BioPharma, Inc.'s tech stack below.
| Immugen BioPharma, Inc. Email Formats | Percentage |
| First.Last@immugen.com | 67% |
| FiLast@immugen.com | 33% |
Biotechnology ResearchFlorida, United States2-10 Employees
Our mission is to harness the endocannabinoid system for women's health based on results from an NIH funded grant.
Immugen BioPharma, Inc.'s revenue is estimated to be in the range of $1M$10M
Immugen BioPharma, Inc.'s revenue is estimated to be in the range of $1M$10M